Central Nervous System Drugs Market Global Briefing 2018

Starting Price : $ 1000.00 | Pages : 35 | Published : January 2018 | SKU CODE : 2767 | Format :

The central nervous system drugs market includes medications that are used in the treatment of diseases affecting the brain or spinal cord. The central nervous system (CNS) integrates sensory information and instructs the body to respond accordingly. The spinal cord is a channel for signals between the brain and the rest of the body. Central nervous system (CNS) disorder is a condition in which the brain and spinal cord’s ability to function is affected, hence affecting the body. The market for CNS disorder drugs comprises of drugs that work in different ways depending on the type of disease by suppressing or boosting the brain activities.

The top five companies covered are Biogen Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Pfizer Inc. and Novartis AG. Biogen Idec was the largest company in the central nervous system drugs market in 2017.

The countries covered are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.

The global central nervous system drugs market was valued at around $71 billion in 2017. North America was the largest region in the central nervous system drugs market in 2017, accounting for nearly 40% market share. The USA was the largest country in the market in 2017, accounting for nearly 30% market share.

Pharmaceutical companies are partnering with technology companies and incorporating wearables in clinical studies and for research and development of CNS disease treatments. These wearable devices make use of sensors to detect early symptoms of Parkinson’s disease such as tremors, slowness and stiffness in patients. Researchers use this data to gain insights about the disease and potential drug reactions, and thus reduce the time for trials by 30% to 50%.

The central nervous system drugs market is segmented into Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics Drugs (AED) and Other Central Nervous System Drugs. Analgesics relieve pain selectively without blocking the conduction of nerve impulses, noticeably changing sensory perception, or affecting consciousness. Anti-Parkinson Drugs are used to treat symptoms of Parkinson's disease and other forms of Parkinsonism which are caused by the lack of neurotransmitter dopamine in the brain. Anesthetics cause unconsciousness and unresponsiveness to the body by suppressing responses to sensory stimulation in the brain. Anti-Epileptics Drugs (AED) also known as anticonvulsants, are preventative drugs used to control epileptic seizures, however they do not cure epilepsy. Other Central Nervous System Drugs includes Antiemetics, Muscle Relaxants and Sedatives.

New Report Shows Telemedicine Technology Market Offers Great Opportunities with 20% Growth a Year

New Report Finds That Pain Management Wearable Devices Are Set to Double, Present Significant Opportunities

Minor Orthopedic Replacement Implants Global Market Exceeds $1.5 Billion

Minor orthopedic implant market to be worth $2.2 billion by 2021, analysts say

Organs-on-Chips to Revolutionize the Drug Development Industry

Russia’s Musculoskeletal Drugs Market Is Catching Up With The Rest Of Europe

The Fastest Growing Regions for Dermatological Drug Sales Are the Middle East and South America

Growth of Middle Class Is Causing Heart Drugs Market In Asia Pacific To Accelerate, Says TBRC

Blood Glucose Test Strips Global Market Report 2018

View Report

Veterinary Services Global Market Report 2018

View Report

Podiatry Services Global Market Strategies and Opportunities to 2021

View Report

Minor Orthopedic Implants Replacement Global Market Opportunities And Strategies To 2021

View Report

Biologics Global Market Opportunities And Strategies To 2021

View Report

Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021

View Report

Blood Glucose Test Strips Global Market Opportunities And Strategies To 2021

View Report

Veterinary Serices Global Market Opportunities And Strategies To 2021

View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)